Early peanut introduction in infants linked to big drop in allergy diagnoses, new CHOP study finds
A new 2025 CHOP study of more than 120,000 pediatric electronic health records found early peanut introduction coincided with a 27% drop in peanut allergy diagnoses and a 38% fall in overall food allergy diagnoses among U.S. children.
- Large observational analysis: CHOP researchers reviewed >120,000 EHRs and observed a 27% decline in peanut allergy and a 38% decline in overall food-allergy diagnoses after wider early-introduction practice.
- Real-world impact: Results support that guideline-driven early peanut introduction is associated with meaningful reductions in diagnoses, though causation is not proven.
- Practical guidance: Current recommendations favor supervised early peanut introduction (around 4–6 months for many infants); consult a pediatrician for high-risk babies.
Study details and findings
Published Oct. 20, 2025 in Pediatrics, the Children’s Hospital of Philadelphia (CHOP) team analyzed electronic health records from more than 120,000 children across dozens of U.S. pediatric clinics. The team asked whether the landmark LEAP trial findings and subsequent guideline changes produced measurable differences in everyday pediatric practice.
Their observational analysis found children whose records reflected early peanut introduction were less likely to be diagnosed with peanut allergy. The study reported a 27% decrease in peanut allergy diagnoses and a 38% drop in overall food-allergy diagnoses after wider adoption of earlier peanut introduction. The team also documented declines in diagnoses for other common allergens, with egg now the most common allergen.
For the CHOP news release on the study, see CHOP news release. For summary coverage, see summary coverage.
Timeframe and context
The analysis covers a two-year period after the National Institute of Allergy and Infectious Diseases (NIAID) encouraged earlier peanut introduction. The CHOP authors note the study captures behavior change through early 2019 — before the 2021 expansion of guidance to multiple allergens — meaning it reflects earlier waves of clinical practice change. See the CHOP news release and Fox News summary for additional context.
Why this matters
For decades families were advised to delay peanut exposure. High-quality randomized trials — most notably the LEAP trial, which showed high-risk infants given peanut at 4–11 months had an 81% lower risk of peanut allergy — drove a major shift in clinical guidance. The CHOP study provides encouraging evidence that those trial results translated into real-world public-health gains.
“These findings support the public-health value of early-introduction guidance and underscore the need for increased education for parents and clinicians,” wrote study authors led by Stanislaw Gabryszewski, M.D., Ph.D.
Practical guidance for parents and pediatricians
- When to start: Introduce smooth peanut butter or thinned peanut products around 4–6 months for many infants. Infants with eczema or egg allergy may need evaluation first and might start around 4 months under clinical guidance (see Fox News report and ACAAI guidance).
- Frequency and form: Small amounts, roughly twice a week through the first year, can help build tolerance; do not give whole peanuts to infants because of choking risk (see Lurie Children’s report).
- When to seek help: Talk with your pediatrician — infants with severe eczema or known egg allergy may need testing or supervised feeding in clinic (see Fox News summary).
Clinician training and adoption
Medical groups report growing clinician adoption helped by new training tools; a 2025 report found improved clinician adherence to early-introduction guidance after targeted training interventions (see training tools report).
However, surveys indicate many parents remain confused about timing and who is high-risk — a gap that local pediatricians can close with clear counseling and practical handouts (see Lurie Children’s report).
Limits of the research
Important caveats: The CHOP study is observational and relies on EHR data that may not capture every feeding detail or diagnosis. Its timeframe ends in early 2019, before 2021 guidance broadened early introduction to multiple allergens. As the authors note, the study shows an association but cannot definitively prove that early peanut introduction caused the decline; other factors such as changes in testing, coding, or diagnostic practices could contribute. See the CHOP news release and news coverage.
Voices in the field
Study authors, led by Stanislaw Gabryszewski, M.D., Ph.D., emphasized that the findings support early-introduction guidance while calling for continued education of parents and clinicians (CHOP news release). Allergy groups such as the American College of Allergy, Asthma & Immunology note rising parental confidence and wider adoption, while practicing allergists remind families to be prepared to treat severe reactions with epinephrine when needed.
Implications for Redding, California
Economic impact: Fewer diagnoses could reduce emergency visits for anaphylaxis and lower long-term costs for testing and specialty care in Redding’s employer-based and public-clinic populations. See the broader study background at the CHOP news release.
Policy and schools: Local leaders favor clear information and access to pediatric guidance rather than mandates. Over time, school and daycare policies may evolve as prevalence changes; local districts should maintain evidence-based allergy management and emergency-response plans.
Social and cultural effects: Many Redding families may welcome a simple, practical prevention step that fits community values. Faith- and community-based groups that host family events may consider updated guidance when planning infant-friendly offerings.
Practical local steps for Redding clinicians and officials
- Update clinic materials and workflows to encourage evidence-based early introduction and provide clear handouts on safe first feeds.
- Ensure hospitals and urgent-care centers continue to stock epinephrine and train staff in recognition and response.
- Offer clinician training using new tools that have been shown to boost adherence to early-introduction guidance (see training tools report).
- Track local adoption through clinic records to measure community impact, mirroring the EHR-based approach of the CHOP study.
Resources and further reading
- CHOP news release on the study
- Fox News summary
- ACAAI overview of early-introduction impact
- National Peanut Board report
- Lurie Children’s report on parent understanding
- JAMA Network study on clinician practices
- Northwestern University coverage of training tools
For Redding parents: what to do now
If you live in Redding and are wondering what to do next: talk with your child’s pediatrician about early peanut introduction, especially if your baby has eczema or other allergic conditions. Local clinics can advise on safe first feeds and whether testing or supervised introduction is appropriate.
Preserve this article’s sources for reference and share them with your pediatrician or school health officials as needed.
